Company intelligence / Profile preview

움트

Seoul Guro-gu, Seoul, South Koreakaimm.org ↗

Ownership: Private
Employees: ~20
Development stage: Other

Overview

움트 is a South Korean contract research organization (CRO) and consulting firm specializing in clinical trial planning and management for pharmaceuticals, medical devices, cosmetics, and health functional foods. The company provides services from preclinical through Phase 4 studies as well as regulatory support for medical device approval. It also engages in marketing/promotion for pharma/cosmetics companies and operates its own brands such as TheMedicalLine and M-Line

Therapeutic areas: Other
Modalities: Small moleculeMedical deviceHealth functional food
Industry: Contract Research Organization

Beyond the preview

Go deeper on 움트.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 움트.

Explore the full profile